Effectiveness of mild ovarian stimulation versus GnRH agonist protocol in women undergoing assisted reproductive technology: a meta-analysis

References

• Al-Inany HG, Youssef MA, Aboulghar M, et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev 2016;4:CD001750
   PubMedGoogle Scholar
• Setti AS, Figueira RC, Braga DP, et al. Relationship between oocyte abnormal morphology and intracytoplasmic sperm injection outcomes: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 2011;159:364–70
   PubMed Web of Science ®Google Scholar
• Shrestha D, La X, Feng HL. Comparison of different stimulation protocols used in in vitro fertilization: a review. Ann Transl Med 2015;3:137
   PubMed Web of Science ®Google Scholar
• Zhang J, Chang L, Sone Y, Silber S. Minimal ovarian stimulation (mini-IVF) for IVF utilizing vitrification and cryopreserved embryo transfer. Reprod Biomed Online 2010;21:485–95
   PubMed Web of Science ®Google Scholar
• Trounson AO, Leeton J F, Wood C, Webb J, et al. Pregnancies in humans by fertilization in vitro and embryo transfer in the controlled ovulatory cycle. Science 1981;212:681–2
   PubMed Web of Science ®Google Scholar
• Lopata A. Concepts in human in vitro fertilization and embryo transfer. Fertil Steril 1983;40:289–301
   PubMed Web of Science ®Google Scholar
• Vargyas JM, Morente C, Shangold G, Marrs RP. The effect of different methods of ovarian stimulation for human in vitro fertilization and embryo replacement. Fertil Steril 1984;42:745–9
   PubMed Web of Science ®Google Scholar
• Macklon NS, Stouffer RL, Giudice LC, Fauser BCJM. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev 2006;27:170–207
   PubMed Web of Science ®Google Scholar
• Nastri CO, Ferriani RA, Rocha IA, et al. Ovarian hyperstimulation syndrome: pathophysiology and prevention. J Assist Reprod Genet 2010;27:121–8
   PubMed Web of Science ®Google Scholar
• de Klerk C, Heijnen EMEW, Macklon NS, et al. The psychological impact of mild ovarian stimulation combined with single embryo transfer compared with conventional IVF. Hum Reprod 2006;21:721–7
   PubMed Web of Science ®Google Scholar
• Fauser BC, Devroey P, Yen SS, et al. Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Hum Reprod 1999;14:2681–6
   PubMed Web of Science ®Google Scholar
• Huirne JA, Homburg R, Lambalk CB. Are GnRH antagonists comparable to agonists for use in IVF? Hum Reprod 2007;22:2805–13
   PubMed Web of Science ®Google Scholar
• Wadhwa L, Khanna R, Gupta T, et al. Evaluation of role of GnRH antagonist in intrauterine insemination (IUI) cycles with mild ovarian hyperstimulation (MOH): a prospective randomised study. J Obstet Gynecol India 2016;66:459–65
   PubMed Web of Science ®Google Scholar
• Branigan EF, Estes MA. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression. Fertil Steril 2000;73:587–90
   PubMed Web of Science ®Google Scholar
• D'Amato G, Caroppo E, Pasquadibisceglie A, et al. A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years. Fertil Steril 2004;81:1572–7
   PubMed Web of Science ®Google Scholar
• Lazer T, Dar S, Shlush E, et al. Comparison of IVF outcomes between minimal stimulation and high-dose stimulation for patients with poor ovarian reserve. Int J Reprod Med 2014;2014:581451
   PubMedGoogle Scholar
• Ozcan Cenksoy P, Ficicioglu C, Kizilkale O, et al. The comparison of effect of microdose GnRH-a flare-up, GnRH antagonist/aromatase inhibitor letrozole and GnRH antagonist/clomiphene citrate protocols on IVF outcomes in poor responder patients. Gynecol Endocrinol 2014;30:485–9
   PubMed Web of Science ®Google Scholar
• Verberg MF, Verberg MFG, Macklon NS, et al. Mild ovarian stimulation for IVF. Hum Reprod Update 2009;15:13–29
   PubMed Web of Science ®Google Scholar
• Revelli A, Casano S, Salvagno F, et al. Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization. Reprod Biol Endocrinol 2011;9:25
   PubMed Web of Science ®Google Scholar
• Heijnen EM, Heijnen EMEW, Eijkemans MJC, et al. A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet 2007;369:743–9
   PubMed Web of Science ®Google Scholar
• Hwang JL, Huang L-W, Hsieh B-C, et al. Ovarian stimulation by clomiphene citrate and hMG in combination with cetrorelix acetate for ICSI cycles. Hum Reprod 2003;18:45–9
   PubMed Web of Science ®Google Scholar
• Weigert M, Krischker U, Pöhl M, et al. Comparison of stimulation with clomiphene citrate in combination with recombinant follicle-stimulating hormone and recombinant luteinizing hormone to stimulation with a gonadotropin-releasing hormone agonist protocol: a prospective, randomized study. Fertil Steril 2002;78:34–9
   PubMed Web of Science ®Google Scholar
• Gibreel A, Maheshwari A, Bhattacharya S. Clomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilization. Cochrane Database Syst Rev 2012;11:CD008528
   PubMedGoogle Scholar
• Figueiredo JB, Nastri CO, Vieira AD, et al. Clomiphene combined with gonadotropins and GnRH antagonist versus conventional controlled ovarian hyperstimulation without clomiphene in women undergoing assisted reproductive techniques: systematic review and meta-analysis. Arch Gynecol Obstet 2013;287:779–90
   PubMed Web of Science ®Google Scholar
• Furlan AD, Malmivaara A, Chou R, et al. 2015 Updated method guideline for systematic reviews in the Cochrane Back and Neck Group. Spine (Phila Pa 1976) 2015;40:1660–73
   PubMed Web of Science ®Google Scholar
• Revelli A, Chiadò A, Dalmasso P, et al. “Mild” vs. “long” protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial. J Assist Reprod Genet 2014;31:809–15
   PubMed Web of Science ®Google Scholar
• Karimzadeh MA, Mashayekhy M, Mohammadian F, et al. Comparison of mild and microdose GnRH agonist flare protocols on IVF outcome in poor responders. Arch Gynecol Obstet 2011;283:1159–64
   PubMed Web of Science ®Google Scholar
• Karimzadeh MA, Ahmadi S, Oskouian H, Rahmani E. Comparison of mild stimulation and conventional stimulation in ART outcome. Arch Gynecol Obstet 2010;281:741–6
   PubMed Web of Science ®Google Scholar
• Lin YH, Hwang JL, Seow KM, et al. Comparison of outcome of clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol and buserelin long protocol–a randomized study. Gynecol Endocrinol 2006;22:297–302
   PubMed Web of Science ®Google Scholar
• Mansour R, Aboulghar MA, Serour GI. The use of clomiphene citrate/human menopausal gonadotrophins in conjunction with GnRH antagonist in an IVF/ICSI program is not a cost effective protocol. Acta Obstet Gynecol Scand 2003;82:48–52
   PubMed Web of Science ®Google Scholar
• Teramoto S, Kato O. Minimal ovarian stimulation with clomiphene citrate: a large-scale retrospective study. Reprod Biomed Online 2007;15:134–48
   PubMed Web of Science ®Google Scholar
• Zarek SM, Muasher SJ. Mild/minimal stimulation for in vitro fertilization: an old idea that needs to be revisited. Fertil Steril 2011;95:2449–55
   PubMed Web of Science ®Google Scholar
• Groen H, Tonch N, Simons AH, et al. Modified natural cycle versus controlled ovarian hyperstimulation IVF: a cost-effectiveness evaluation of three simulated treatment scenarios. Hum Reprod 2013;28:3236–46
   PubMed Web of Science ®Google Scholar
• Pal L, Jindal S, Witt BR, Santoro N. Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertil Steril 2008;89:1694–701
   PubMed Web of Science ®Google Scholar
• Lekamge DN, Lane M, Gilchrist RB, Tremellen KP. Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve. J Assist Reprod Genet 2008;25:515–21
   PubMed Web of Science ®Google Scholar
• Check JH, Summers-Chase D, Yuan W, et al. Effect of embryo quality on pregnancy outcome following single embryo transfer in women with a diminished egg reserve. Fertil Steril 2007;87:749–56
   PubMed Web of Science ®Google Scholar
• Mocanu E, Redmond ML, Hennelly B, et al. Odds of ovarian hyperstimulation syndrome (OHSS)—time for reassessment. Hum Fertil (Camb) 2007;10:175–81
   PubMedGoogle Scholar
• Copperman AB, Benadiva C. Optimal usage of the GnRH antagonists: a review of the literature. Reprod Biol Endocrinol 2013;11:20
   PubMed Web of Science ®Google Scholar
• Helmerhorst FM, Perquin DAM, Donker D, Keirse MJNC. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. BMJ 2004;328:261
   PubMed Web of Science ®Google Scholar
• Fauser BC, Devroey P, Macklon NS. Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet 2005;365:1807–16
   PubMed Web of Science ®Google Scholar